[1]
Liu, T. et al. 2024. Astragaloside IV suppresses the proliferation and inflammatory response of human epidermal keratinocytes and ameliorates imiquimod-induced psoriasis-like skin damage in mice. Allergologia et Immunopathologia. 52, 5 (Sep. 2024), 44–50. DOI:https://doi.org/10.15586/aei.v52i5.1140.